title: [Highlights of the Congress of the National Infectious Disease Medicine Days 2010].
authors.affiliation: CHU Grenoble, France. cwintenberger@chu-grenoble.fr
authors.forename: C
authors.initials: C
authors.lastname: Wintenberger
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001170:Arthritis, Infectious / Q000188:drug therapy; D001372:Aza Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D002986:Clinical Trials as Topic / Q000379:methods; D004352:Drug Resistance, Microbial; D024841:Fluoroquinolones; D005602:France; D006801:Humans; D055552:Infectious Disease Medicine; D000077266:Moxifloxacin; D015337:Multicenter Studies as Topic; D010000:Osteitis / Q000188:drug therapy; D016459:Prosthesis-Related Infections / Q000188:drug therapy; D011804:Quinolines / Q000008:administration & dosage / Q000627:therapeutic use; D012955:Societies, Medical; D016896:Treatment Outcome; D001618:beta-Lactamases / Q000378:metabolism
chemical_list: D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D001618:beta-Lactamases; D000077266:Moxifloxacin